Inspire Medical Systems, Inc. Cash Flow Statement
INSP / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 10 fiscal years. All figures from audited SEC 10-K filings.
Inspire Medical Systems, Inc. generated $117M in operating cash flow and $78M in free cash flow in FY2025. Free cash flow margin was 8.6% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $145.4M | $53.5M | -$21.2M | -$44.9M | -$42.0M | -$57.2M | -$33.2M | -$21.8M | -$17.5M | -$18.5M |
| Depreciation & Amortization | $14.0M | $6.5M | $2.8M | $1.9M | $1.2M | $840.0K | $495.0K | $393.0K | $285.0K | $103.0K |
| Operating Cash Flow | $117.0M | $130.2M | $24.7M | $11.6M | -$20.1M | -$53.0M | -$32.8M | -$18.7M | -$15.8M | -$17.9M |
| Capital Expenditures | $38.5M | $39.1M | $23.6M | $9.1M | $4.7M | $2.5M | $2.7M | $250.0K | $412.0K | $306.0K |
| Free Cash Flow | $78.5M | $91.1M | $1.0M | $2.5M | -$24.8M | -$55.5M | -$35.6M | -$18.9M | -$16.2M | -$18.3M |
| Share Buybacks | $175.0M | $0 | $0 | $0 | - | - | - | - | - | - |
| FCF Margin | 8.6% | 11.3% | 0.2% | 0.6% | -10.6% | -48.1% | -43.4% | -37.4% | - | - |